Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Dec;78(12):7712-6.
doi: 10.1073/pnas.78.12.7712.

Increased responses to lymphokines are correlated with preleukemia in mice inoculated with Moloney leukemia virus

Increased responses to lymphokines are correlated with preleukemia in mice inoculated with Moloney leukemia virus

J C Lee et al. Proc Natl Acad Sci U S A. 1981 Dec.

Abstract

In various mouse strains, inoculation with Moloney leukemia virus results in the establishment of an acute viremia which in most cases is followed by the induction of leukemia. Also associated with the viremia is the development of a chronic cellular immune response detectable in vitro by the ability of viral proteins to induce splenic lymphocyte proliferation. Previous studies have demonstrated that, in the absence of this cellular immune response, leukemia does not develop irrespective of whether viremia is present [Lee, J. C. & Ihle, J. N. (1981) Nature (London) 289, 407-409]. In vitro proliferative responses to antigens involve the nonspecific response of various subpopulations of lymphocytes to lymphokines produced by antigen-specific Thy 1+, Lyt 1+,2- lymphocytes. The studies presented here concern the effects of a chronic immune response in viremic mice on the frequency of lymphocytes capable of responding to lymphokines in vitro. The data demonstrate that the number of responsive lymphocytes is increased 30- to 100-fold in preleukemic mice and that such increases are dependent upon the induction of an immune response in viremic mice. The role of this altered immune response in leukemia is discussed.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1515-7 - PubMed
    1. J Immunol. 1977 Mar;118(3):928-34 - PubMed
    1. J Immunol. 1979 Feb;122(2):665-74 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 May;76(5):2442-6 - PubMed
    1. Cell. 1979 May;17(1):65-75 - PubMed

Publication types

LinkOut - more resources